{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:56:07Z","timestamp":1769154967932,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Science and Technology, Government of India, Department of Biotechnology, Government of India","award":["SB\/SO\/HS\/204\/2013"],"award-info":[{"award-number":["SB\/SO\/HS\/204\/2013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4157-2","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T14:03:21Z","timestamp":1561989801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Aerosol immunization by alginate coated mycobacterium (BCG\/MIP) particles provide enhanced immune response and protective efficacy than aerosol of plain mycobacterium against M.tb. H37Rv infection in mice"],"prefix":"10.1186","volume":"19","author":[{"given":"Puja S.","family":"Nagpal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani","family":"Kesarwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-822X","authenticated-orcid":false,"given":"Pramod","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"4157_CR1","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","volume":"346","author":"PE Fine","year":"1995","unstructured":"Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet (London, England). 1995;346:1339\u201345 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7475776 . Accessed 4 Aug 2018.","journal-title":"Lancet (London, England)"},{"key":"4157_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1586\/14760584.7.5.635","volume":"7","author":"LH Ly","year":"2008","unstructured":"Ly LH, McMurray DN. Tuberculosis: vaccines in the pipeline. Expert Rev Vaccines. 2008;7:635\u201350. https:\/\/doi.org\/10.1586\/14760584.7.5.635 .","journal-title":"Expert Rev Vaccines"},{"key":"4157_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4161\/hv.6.8.13188","volume":"6","author":"SHE Kaufmann","year":"2010","unstructured":"Kaufmann SHE. Learning from natural infection for rational tuberculosis vaccine design: from basic science to translational research. Hum Vaccin. 2010;6:614\u20138. https:\/\/doi.org\/10.4161\/hv.6.8.13188 .","journal-title":"Hum Vaccin"},{"key":"4157_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1473-3099(11)70146-3","volume":"11","author":"SHE Kaufmann","year":"2011","unstructured":"Kaufmann SHE. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect Dis. 2011;11:633\u201340. https:\/\/doi.org\/10.1016\/S1473-3099(11)70146-3 .","journal-title":"Lancet Infect Dis"},{"key":"4157_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","volume":"33","author":"SHE Kaufmann","year":"2010","unstructured":"Kaufmann SHE. Future vaccination strategies against tuberculosis: thinking outside the box. Immunity. 2010;33:567\u201377. https:\/\/doi.org\/10.1016\/j.immuni.2010.09.015 .","journal-title":"Immunity"},{"key":"4157_CR6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/infdis\/jir592","volume":"204","author":"C Desel","year":"2011","unstructured":"Desel C, Dorhoi A, Bandermann S, Grode L, Eisele B, Kaufmann SHE. Recombinant BCG \u0394ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses. J Infect Dis. 2011;204:1573\u201384. https:\/\/doi.org\/10.1093\/infdis\/jir592 .","journal-title":"J Infect Dis"},{"key":"4157_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/2051013615593891","volume":"3","author":"MJ Ahsan","year":"2015","unstructured":"Ahsan MJ. Recent advances in the development of vaccines for tuberculosis. Ther Adv Vaccines. 2015;3:66\u201375. https:\/\/doi.org\/10.1177\/2051013615593891 .","journal-title":"Ther Adv Vaccines"},{"key":"4157_CR8","first-page":"209","volume":"83","author":"CA Thaiss","year":"2010","unstructured":"Thaiss CA, Kaufmann SHE. Toward novel vaccines against tuberculosis: current hopes and obstacles. Yale J Biol Med. 2010;83:209\u201315 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21165340 . Accessed 15 Jan 2019.","journal-title":"Yale J Biol Med"},{"key":"4157_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/IAI.00526-08","volume":"77","author":"A Gupta","year":"2009","unstructured":"Gupta A, Geetha N, Mani J, Upadhyay P, Katoch VM, Natrajan M, et al. Immunogenicity and protective efficacy of \u201cMycobacterium w\u201d against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route. Infect Immun. 2009;77:223\u201331. https:\/\/doi.org\/10.1128\/IAI.00526-08 .","journal-title":"Infect Immun"},{"key":"4157_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","volume":"101","author":"S Sharpe","year":"2016","unstructured":"Sharpe S, White A, Sarfas C, Sibley L, Gleeson F, McIntyre A, et al. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations. Tuberculosis (Edinburgh, Scotland). 2016;101:174\u201390. https:\/\/doi.org\/10.1016\/j.tube.2016.09.004 .","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"4157_CR11","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.1016\/j.vaccine.2007.07.005","volume":"25","author":"S-A Hwang","year":"2007","unstructured":"Hwang S-A, Wilk KM, Budnicka M, Olsen M, Bangale YA, Hunter RL, et al. Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis. Vaccine. 2007;25:6730\u201343. https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.005 .","journal-title":"Vaccine"},{"key":"4157_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2005.01.014","volume":"104","author":"ZK Carpenter","year":"2005","unstructured":"Carpenter ZK, Williamson ED, Eyles JE. Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu. J Control Release. 2005;104:67\u201377. https:\/\/doi.org\/10.1016\/j.jconrel.2005.01.014 .","journal-title":"J Control Release"},{"key":"4157_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijpharm.2008.10.016","volume":"369","author":"C Plumley","year":"2009","unstructured":"Plumley C, Gorman EM, El-Gendy N, Bybee CR, Munson EJ, Berkland C. Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy. Int J Pharm. 2009;369:136\u201343. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.10.016 .","journal-title":"Int J Pharm"},{"key":"4157_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s11095-007-9381-6","volume":"25","author":"J Fiegel","year":"2008","unstructured":"Fiegel J, Garcia-Contreras L, Thomas M, VerBerkmoes J, Elbert K, Hickey A, et al. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin. Pharm Res. 2008;25:805\u201311. https:\/\/doi.org\/10.1007\/s11095-007-9381-6 .","journal-title":"Pharm Res"},{"key":"4157_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2006.10.009","volume":"333","author":"K Hadinoto","year":"2007","unstructured":"Hadinoto K, Phanapavudhikul P, Kewu Z, Tan RBH. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids. Int J Pharm. 2007;333:187\u201398. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.10.009 .","journal-title":"Int J Pharm"},{"key":"4157_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1021\/acs.molpharmaceut.7b01062","volume":"15","author":"M Ibrahim","year":"2018","unstructured":"Ibrahim M, Hatipoglu MK, Garcia-Contreras L. SHetA2 dry powder aerosols for tuberculosis: formulation, design, and optimization using quality by design. Mol Pharm. 2018;15:300\u201313. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b01062 .","journal-title":"Mol Pharm"},{"key":"4157_CR17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s11095-008-9547-x","volume":"25","author":"A Clark","year":"2008","unstructured":"Clark A, Kuo M-C, Newman S, Hirst P, Pitcairn G, Pickford M. A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin. Pharm Res. 2008;25:1583\u201390. https:\/\/doi.org\/10.1007\/s11095-008-9547-x .","journal-title":"Pharm Res"},{"key":"4157_CR18","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.vaccine.2006.10.019","volume":"25","author":"RL de Swart","year":"2007","unstructured":"de Swart RL, LiCalsi C, Quirk AV, van Amerongen G, Nodelman V, Alcock R, et al. Measles vaccination of macaques by dry powder inhalation. Vaccine. 2007;25:1183\u201390. https:\/\/doi.org\/10.1016\/j.vaccine.2006.10.019 .","journal-title":"Vaccine"},{"key":"4157_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/IAI.8.4.497-502.1973","volume":"8","author":"R Ganguly","year":"1973","unstructured":"Ganguly R, Ogra PL, Regas S, Waldman RH. Rubella immunization of volunteers via the respiratory tract. Infect Immun. 1973;8:497\u2013502 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4200537 . Accessed 15 Jan 2019.","journal-title":"Infect Immun"},{"key":"4157_CR20","first-page":"1161","volume":"50","author":"BL Laube","year":"2005","unstructured":"Laube BL. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Respir Care. 2005;50:1161\u201376 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16122400 . Accessed 15 Jan 2019.","journal-title":"Respir Care"},{"issue":"6","key":"4157_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1089\/jamp.2017.1379","volume":"30","author":"Tejal Rawal","year":"2017","unstructured":"Rawal T, Kremer L, Halloum I, Butani S. Dry-powder inhaler formulation of rifampicin: an improved targeted delivery system for alveolar tuberculosis. J Aerosol Med Pulm Drug Deliv. 2017;30. https:\/\/doi.org\/10.1089\/jamp.2017.1379 .","journal-title":"Journal of Aerosol Medicine and Pulmonary Drug Delivery"},{"key":"4157_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/0962-8479(93)90067-8.","volume":"74","author":"M Lagranderie","year":"1993","unstructured":"Lagranderie M, Ravisse P, Marchal G, Gheorghiu M, Balasubramanian V, Weigeshaus EH, et al. BCG-induced protection in Guinea pigs vaccinated and challenged via the respiratory route. Tuber Lung Dis. 1993;74:38\u201346. https:\/\/doi.org\/10.1016\/0962-8479(93)90067-8.","journal-title":"Tuber Lung Dis"},{"key":"4157_CR23","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/AAC.01471-09","volume":"54","author":"L Garcia-Contreras","year":"2010","unstructured":"Garcia-Contreras L, Sung JC, Muttil P, Padilla D, Telko M, VerBerkmoes JL, et al. Dry powder PA-824 aerosols for treatment of tuberculosis in Guinea pigs. Antimicrob Agents Chemother. 2010;54:1436\u201342. https:\/\/doi.org\/10.1128\/AAC.01471-09 .","journal-title":"Antimicrob Agents Chemother"},{"key":"4157_CR24","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1073\/pnas.0800043105","volume":"105","author":"L Garcia-Contreras","year":"2008","unstructured":"Garcia-Contreras L, Wong Y-L, Muttil P, Padilla D, Sadoff J, DeRousse J, et al. Immunization by a bacterial aerosol. Proc Natl Acad Sci. 2008;105:4656\u201360. https:\/\/doi.org\/10.1073\/pnas.0800043105 .","journal-title":"Proc Natl Acad Sci"},{"key":"4157_CR25","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1073\/pnas.0611430104","volume":"104","author":"Y-L Wong","year":"2007","unstructured":"Wong Y-L, Sampson S, Germishuizen WA, Goonesekera S, Caponetti G, Sadoff J, et al. Drying a tuberculosis vaccine without freezing. Proc Natl Acad Sci. 2007;104:2591\u20135. https:\/\/doi.org\/10.1073\/pnas.0611430104 .","journal-title":"Proc Natl Acad Sci"},{"key":"4157_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jbm.a.30131","volume":"71","author":"M Yoshida","year":"2004","unstructured":"Yoshida M, Babensee JE. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A. 2004;71:45\u201354. https:\/\/doi.org\/10.1002\/jbm.a.30131 .","journal-title":"J Biomed Mater Res A"},{"key":"4157_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1163\/156856206777996844","volume":"17","author":"M Yoshida","year":"2006","unstructured":"Yoshida M, Babensee JE. Molecular aspects of microparticle phagocytosis by dendritic cells. J Biomater Sci Polym Ed. 2006;17:893\u2013907 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17024879 . Accessed 15 Jan 2019.","journal-title":"J Biomater Sci Polym Ed"},{"key":"4157_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/jbm.a.30798","volume":"79A","author":"M Yoshida","year":"2006","unstructured":"Yoshida M, Babensee JE. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res A. 2006;79A:393\u2013408. https:\/\/doi.org\/10.1002\/jbm.a.30798 .","journal-title":"J Biomed Mater Res A"},{"key":"4157_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jbm.a.30832","volume":"80","author":"M Yoshida","year":"2007","unstructured":"Yoshida M, Mata J, Babensee JE. Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells. J Biomed Mater Res A. 2007;80:7\u201312. https:\/\/doi.org\/10.1002\/jbm.a.30832 .","journal-title":"J Biomed Mater Res A"},{"key":"4157_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.08.039","volume":"365","author":"C Wischke","year":"2009","unstructured":"Wischke C, Zimmermann J, Wessinger B, Schendler A, Borchert H, Peters J, et al. Poly(I:C) coated PLGA microparticles induce dendritic cell maturation. Int J Pharm. 2009;365:61\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.08.039 .","journal-title":"Int J Pharm"},{"key":"4157_CR31","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412 .","journal-title":"PLoS Biol"},{"key":"4157_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0378-5173(03)00023-1","volume":"255","author":"S Bhaskar","year":"2003","unstructured":"Bhaskar S, Upadhyay P. Design and evaluation of an aerosol infection chamber for small animals. Int J Pharm. 2003;255:43\u20138 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12672600 . Accessed 15 Jan 2019.","journal-title":"Int J Pharm"},{"key":"4157_CR33","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","volume":"176","author":"K Inaba","year":"1992","unstructured":"Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor. J Exp Med. 1992;176:1693\u2013702 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1460426 . Accessed 24 Jan 2019.","journal-title":"J Exp Med"},{"key":"4157_CR34","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1128\/JVI.80.4.1826-1836.2006","volume":"80","author":"AT Thiele","year":"2006","unstructured":"Thiele AT, Sumpter TL, Walker JA, Xu Q, Chang C-H, Bacallao RL, et al. Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to Interleukin-2. J Virol. 2006;80:1826\u201336. https:\/\/doi.org\/10.1128\/JVI.80.4.1826-1836.2006 .","journal-title":"J Virol"},{"key":"4157_CR35","doi-asserted-by":"publisher","first-page":"Unit 19.5","DOI":"10.1002\/0471142735.im1905s30","volume":"Chapter 19","author":"IM Orme","year":"2001","unstructured":"Orme IM, Roberts AD. Animal models of mycobacteria infection. Curr Protoc Immunol. 2001;Chapter 19:Unit 19.5. https:\/\/doi.org\/10.1002\/0471142735.im1905s30 .","journal-title":"Curr Protoc Immunol"},{"key":"4157_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1365-2567.2000.00963.x","volume":"99","author":"RE Tascon","year":"2000","unstructured":"Tascon RE, Soares CS, Ragno S, Stavropoulos E, Hirst EM, Colston MJ. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology. 2000;99:473\u201380 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10712679 . Accessed 15 Jan 2019.","journal-title":"Immunology"},{"key":"4157_CR37","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1","volume":"29","author":"C Demangel","year":"1999","unstructured":"Demangel C, Bean AG, Martin E, Feng CG, Kamath AT, Britton WJ. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Gu\u00e9rin-infected dendritic cells. Eur J Immunol. 1999;29:1972\u20139. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1 .","journal-title":"Eur J Immunol"},{"key":"4157_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.colsurfb.2010.07.050","volume":"81","author":"S Alipour","year":"2010","unstructured":"Alipour S, Montaseri H, Tafaghodi M. Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery. Colloids Surf B: Biointerfaces. 2010;81:521\u20139. https:\/\/doi.org\/10.1016\/j.colsurfb.2010.07.050 .","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"4157_CR39","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.4049\/jimmunol.163.7.3890","volume":"163","author":"SS Ahuja","year":"1999","unstructured":"Ahuja SS, Reddick RL, Sato N, Montalbo E, Kostecki V, Zhao W, et al. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J Immunol (Baltimore, Md: 1950). 1999;163:3890\u20137 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10490989 . Accessed 15 Jan 2019.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"4157_CR40","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ymthe.2005.10.018","volume":"13","author":"JI Malowany","year":"2006","unstructured":"Malowany JI, McCormick S, Santosuosso M, Zhang X, Aoki N, Ngai P, et al. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Mol Ther. 2006;13:766\u201375. https:\/\/doi.org\/10.1016\/j.ymthe.2005.10.018 .","journal-title":"Mol Ther"},{"key":"4157_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0021-8502(86)90035-2","volume":"17","author":"J Heyder","year":"1986","unstructured":"Heyder J, Gebhart J, Rudolf G, Schiller CF, Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005\u201315 \u03bcm. J Aerosol Sci. 1986;17:811\u201325. https:\/\/doi.org\/10.1016\/0021-8502(86)90035-2 .","journal-title":"J Aerosol Sci"},{"key":"4157_CR42","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ejpb.2008.01.009","volume":"69","author":"H Hoyer","year":"2008","unstructured":"Hoyer H, Schlocker W, Krum K, Bernkop-Schn\u00fcrch A. Preparation and evaluation of microparticles from thiolated polymers via air jet milling. Eur J Pharm Biopharm. 2008;69:476\u201385. https:\/\/doi.org\/10.1016\/j.ejpb.2008.01.009 .","journal-title":"Eur J Pharm Biopharm"},{"key":"4157_CR43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ejpb.2005.09.001","volume":"62","author":"W Schlocker","year":"2006","unstructured":"Schlocker W, Gschliesser S, Bernkop-Schn\u00fcrch A. Evaluation of the potential of air jet milling of solid protein-poly(acrylate) complexes for microparticle preparation. Eur J Pharm Biopharm. 2006;62:260\u20136. https:\/\/doi.org\/10.1016\/j.ejpb.2005.09.001 .","journal-title":"Eur J Pharm Biopharm"},{"key":"4157_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245\u201352. https:\/\/doi.org\/10.1038\/32588 .","journal-title":"Nature"},{"key":"4157_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20071367","volume":"205","author":"AJ Wolf","year":"2008","unstructured":"Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, Takatsu K, et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med. 2008;205:105\u201315. https:\/\/doi.org\/10.1084\/jem.20071367 .","journal-title":"J Exp Med"},{"key":"4157_CR46","doi-asserted-by":"publisher","first-page":"7110","DOI":"10.4049\/jimmunol.1100001","volume":"186","author":"R Blomgran","year":"2011","unstructured":"Blomgran R, Ernst JD. Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. J Immunol (Baltimore, Md: 1950). 2011;186:7110\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1100001 .","journal-title":"J Immunol (Baltimore, Md: 1950)."},{"key":"4157_CR47","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.biomaterials.2006.10.034","volume":"28","author":"S Fischer","year":"2007","unstructured":"Fischer S, Uetz-von Allmen E, Waeckerle-Men Y, Groettrup M, Merkle HP, Gander B. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials. 2007;28:994\u20131004. https:\/\/doi.org\/10.1016\/j.biomaterials.2006.10.034 .","journal-title":"Biomaterials"},{"key":"4157_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1164\/ajrccm.157.3.9708002","volume":"157","author":"NW Schluger","year":"1998","unstructured":"Schluger NW, Rom WN. The host immune response to tuberculosis. Am J Respir Crit Care Med. 1998;157:679\u201391. https:\/\/doi.org\/10.1164\/ajrccm.157.3.9708002 .","journal-title":"Am J Respir Crit Care Med"},{"key":"4157_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1471-4906(02)02281-0","volume":"23","author":"MB Lutz","year":"2002","unstructured":"Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002;23:445\u20139. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12200066 . Accessed 15 Jan 2019.","journal-title":"Trends Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4157-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:08:13Z","timestamp":1694988493000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4157-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4157-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures on animals were approved by the Institutional Animal Ethics Committee of National Institute of immunology, New Delhi, India; certificate numbers IAEC\/149\/06 and IAEC\/354\/14.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"568"}}